Limited Time Offer
Get $1000 towards your
first investment
Start investing in private markets with Linqto – your access to disruptive startups and pre-IPO companies.
*Terms and conditions apply. See details
RefleXion, founded in 2009 and headquartered in Hayward, California, is a therapeutic oncology company specializing in innovative cancer treatments. The company's flagship service, SCINTIX therapy, utilizes signals from cancer cells to deliver targeted treatment for tumors in the lung or bone, addressing both primary and metastatic diseases. RefleXion primarily serves the healthcare industry, particularly cancer treatment centers, with its cutting-edge technology.
Since its inception, RefleXion has demonstrated significant growth potential, having raised a total of approximately $633.6 million in funding. This substantial financial backing suggests investor confidence in the company's innovative approach to cancer treatment and its potential impact on the healthcare industry.
While there is currently no specific news regarding RefleXion's IPO prospects, the company's unique position in the oncology field and its substantial funding history may attract attention from potential investors interested in the healthcare and biotechnology sectors. However, it's important to note that any discussions about a potential IPO for RefleXion remain speculative at this time.
Factors that could influence RefleXion's decision to go public in the future may include market conditions in the healthcare and biotechnology sectors, the company's financial performance, and its strategic growth plans. As with any potential IPO, various internal and external factors would need to be carefully considered before making such a significant decision.
Get $1000 towards your
first investment
*Terms and conditions apply. See details
While RefleXion's IPO prospects remain uncertain, investors interested in the innovative medical technology sector don't have to wait. At Linqto, we offer members access to interests in promising pre-IPO private companies, including potential leaders in healthcare and medical technology. Our platform allows you to diversify your portfolio with lower minimum investments in emerging industry pioneers like RefleXion, potentially benefiting from their growth before they go public.
*These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO. The information provided above is based on current online discussions and is not intended as investment advice. Linqto does not endorse or guarantee the accuracy of this information, and we strongly recommend conducting your own research or consulting with a professional advisor before making any investment decisions. Linqto cannot be held liable for any investment outcomes resulting from the use of this information.
